Meaningful Use Stage 2: Important Implications for Pediatrics
|
|
|
- Frederica Horton
- 9 years ago
- Views:
Transcription
1 Meaningful Use Stage 2: Important Implications for Pediatrics
2 Glossary of Acronyms MU CQM EHR CEHRT EPs CAHs e-rx CPOE emar ONC CMS HHS Meaningful Use Clinical quality measure Electronic health record Certified electronic health record technology Eligible professionals Critical access hospitals Electronic prescribing Computerized Provider Order Entry Electronic medication administration record Office of the National Coordinator Centers for Medicare and Medicaid Services U.S. Department of Health and Human Services
3 Meaningful Use (MU) Defined Promotes the spread of electronic health records to improve health care and seeks to: Improve quality, safety, efficiency, and reduce health disparities Engage patients and family Improve care coordination, population health, and public health Maintain privacy and security of patient health information Stages move from building a foundation for data capturing and sharing to the use of data to improve health outcomes. Stage 1 : Data Capturing and Sharing o Final Rule Released: July 2010 Incentive program: 2011 Stage 2: Advance Clinical Processes o Final Rule Released: August 2012 Incentive program: 2014 Stage 3: Improved Health Outcomes o Timeline to be determined
4 Summary of Final Rule for Stage 2 Amends Stage 1 Defines new criteria for Stage 2 Changes the definition of what constitutes a Medicaid encounter Extends eligibility to hospital based providers Greater emphasis on patient engagement and electronic exchange of information New pediatric specific clinical quality measures (CQMs) and reporting mechanisms
5 Changes from Stage 1 to Stage 2 Stage 1 Stage 2 Eligible Professionals (EPs) 15 Core Objectives 5 of 10 menu objectives 20 total objectives EPs 17 Core Objectives 3 of 6 menu objectives 20 total objectives Eligible Hospitals and Critical Access Hospitals (CAHs) 14 Core Objectives 5 of 10 menu objectives 19 total objectives Eligible Hospitals and CAHs 16 Core Objectives 3 of 6 menu objectives 19 total objectives
6 Stage 2 Core Objectives for EPs Core Objective Measure Use Computerized Provider Order Entry (CPOE) for medication orders Generate and transmit permissible prescriptions electronically (e-rx) Record demographics: Preferred language, gender, race, ethnicity and date of birth. Record and chart changes in vital signs: Height, weight, blood pressure, calculate and display BMI, plot and display growth charts for children 2-20 years, including BMI. Record smoking status for patients 13 years old and older More than 60 percent of medication, 30% laboratory, and 30% radiology orders created during the EHR reporting period are recorded using CPOE. More than 50 percent of all permissible prescriptions written are compared to at least one drug formulary and transmitted electronically using CEHRT. More than 80 percent of all unique patients seen have demographics recorded as structured data. More than 80 percent of all unique patients have blood pressure (for patients age 3 and over only) and height/length and weight (for all ages) recorded as structured data. More than 80 percent of all unique patients 13 years or older have smoking status recorded as structured data.
7 EP Core Objectives (continued) Core Objective Measure Interventions: Implement one clinical decision support rule relevant to specialty or high clinical priority along with the ability to track compliance that rule. Patient Access: Provide patients with an electronic copy of their health information (including diagnostic test results, problem list, medication lists, medication allergies), upon request. Implement 5 clinical decision support interventions related to 4 or more clinical quality measures at a relevant point in patient care for the entire EHR reporting period. Enabled and implemented the functionality for drug-drug and drug-allergy interaction checks for the entire EHR reporting period. More than 50% of all unique patients seen during the EHR reporting period are provided timely (available to the patient within 4 business days after the information is available to the EP) online access to their health information. More than 5% of all unique patients seen by the EP during the EHR reporting period (or their authorized representatives) view, download, or transmit to a third party their health information. Provide clinical summaries for patients for each office visit Incorporate clinical lab-test results into certified EHR technology as structured data Clinical summaries provided to patients within one business day for more than 50% of office visits. More than 55% of all clinical lab tests results ordered during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in CEHRT as structured data.
8 EP Core Objectives (continued) Core Objective Measure Patient Lists: Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research or outreach. Patient Reminders: Send reminders to patients per patient preference for preventive/ follow up care. Generate at least one report listing patients of the EP with a specific condition. Use EHR to identify and provide reminders for preventive/follow-up care for more than 10% of patients with two or more office visits in the last 2 years. Patient Education: Use certified EHR technology to identify patient-specific education resources and provide those resources to the patient if appropriate Patient-specific education resources identified by CEHRT are provided to patients for more than 10% of all unique patients with office visits seen by the EP during the EHR reporting period. The EP who receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation The EP performs medication reconciliation for more than 50% of transitions of care in which the patient is transitioned into the care of the EP.
9 EP Core Objectives (continued) Core Objective The EP who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary of care record for each transition of care or referral Capability to submit electronic data to Immunization Registries or Immunization Information Systems and actual submission except where prohibited and in accordance with applicable law and practice Security Analysis: Protect electronic health information created or maintained by the certified EHR technology through the implementation of appropriate technical capabilities Secure Messaging Measure Provide summary of care document for more than 50% of transitions of care and referrals with 10% sent electronically and at least one sent to a recipient with a different EHR vendor or successfully testing with CMS test EHR. Successful ongoing submission of electronic immunization data from Certified EHR Technology to an immunization registry or immunization information system for the entire EHR reporting period. Conduct or review a security risk analysis in accordance with the requirements under 45 CFR (a)(1). A secure message was sent using the electronic messaging function of CEHRT by more than 5% of unique patients seen during the EHR reporting period.
10 Stage 2 Menu Objectives for EPs Must meet 3 of 6 Menu Objective Measure Imaging Results Family History Submission of syndromic surveillance data More than 10% of all scans and tests whose result is an image ordered for patients seen during the EHR reporting period are incorporated into or accessible through CEHRT More than 20% of all unique patients seen during the EHR reporting period have a structured data entry for one or more first-degree relatives or an indication that family health history has been reviewed Successful ongoing submission of electronic syndromic surveillance data from CEHRT to a public health agency for the entire EHR reporting period Cancer Successful ongoing submission of cancer case information from CEHRT to a cancer registry for the entire EHR reporting period Specialized Registry Successful ongoing submission of specific case information from CEHRT to a specialized registry for the entire EHR reporting period Record electronic notes in patient records Enter at least one electronic progress note created, edited and signed by an EP for more than 30% of unique patients
11 Stage 2 Core Objectives for Hospitals and CAHs Core Objective Use Computerized Provider Order Entry (CPOE) for medication orders Measure More than 60% of medication, 30% of laboratory, and 30% of radiology orders created by authorized providers during the EHR reporting period are recorded using CPOE. Record demographics: Preferred language, gender, race, ethnicity, date of birth., and date and preliminary cause of death More than 80% of all unique patients admitted to the inpatient or emergency department have demographics recorded as structured data Record and chart changes in vital signs: Height, weight, blood pressure, calculate and display BMI, plot and display growth charts for children 2-20 years, including BMI More than 80% of all unique patients admitted to the inpatient or emergency department have blood pressure (for patients age 3 and over only) and height and weight (for all ages) recorded as structured data. Record smoking status for patients 13 years old and older More than 80% of all unique patients 13 years old or older admitted to the inpatient or emergency department have smoking status recorded as structured data
12 Hospitals and CAHs Core Objectives (continued) Core Objective Interventions: Implement one clinical decision support rule relevant to specialty or high clinical priority along with the ability to track compliance that rule Patient Access: Provide patients with an electronic copy of their health information (including diagnostic test results, problem list, medication lists, medication allergies), upon request Incorporate clinical lab-test results into certified EHR technology as structured data Measure Implement 5 clinical decision support interventions related to 4 or more clinical quality measures at a relevant point in patient care for the entire EHR reporting period. Enabled and implemented the functionality for drug-drug and drug-allergy interaction checks for the entire EHR reporting period. More than 50% of all unique patients discharged from the inpatient or emergency departments during the EHR reporting period are provided timely (available to the patient within 36 hours after discharge from the hospital.) online access to their health information More than 5% of all unique patients discharged from the inpatient or emergency departments during the EHR reporting period (or their authorized representatives) view, download, or transmit to a third party their health information More than 55% of all clinical lab tests results ordered by authorized providers for patients admitted to its inpatient or emergency department during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in CEHRT as structured data
13 Hospitals and CAHs Core Objectives (continued) Core Objective Measure Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research or outreach Generate at least one report listing patients with a specific condition Patient education: Use certified EHR technology to identify patient-specific education resources and provide those resources to the patient if appropriate Incorporate clinical lab-test results into certified EHR technology as structured data The eligible hospital or CAH that receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation More than 10% of all unique patients admitted to the inpatient and emergency departments are provided patient- specific education resources identified by CEHRT. More than 55% of all clinical lab tests results ordered by authorized providers for patients admitted to its inpatient or emergency department during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in CEHRT as structured data The eligible hospital or CAH performs medication reconciliation for more than 50% of transitions of care in which the patient is transitioned into the care of the eligible hospital or CAH.
14 Hospitals and CAHs Core Objectives (continued) Core Objective Measure The eligible hospital or CAH that transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary of care record for each transition of care or referral Provide summary of care document for more than 50% of transitions of care and referrals with 10% sent electronically and at least one sent to an organization that is a NwHIN Exchange participant or is validated through an ONC-established governance mechanism. Capability to submit electronic data to Immunization Registries or Immunization Information Systems and actual submission except where prohibited and in accordance with applicable law and practice Successful ongoing submission of electronic immunization data from Certified EHR Technology to an immunization registry or immunization information system for the entire EHR reporting period. Capability to submit electronic data on reportable (as required by state or local law) lab results to public health agencies and actual submission except where prohibited and in accordance with applicable law and practice Successful ongoing submission of electronic reportable laboratory results from CEHRT to public health agencies for the entire EHR reporting period as authorized, and in accordance with applicable State law and practice.
15 Hospitals and CAHs Core Objectives (continued) Core Objective Measure Security Analysis: Protect electronic health information created or maintained by the certified EHR technology through the implementation of appropriate technical capabilities Conduct or review a security risk analysis in accordance with the requirements under 45 CFR (a)(1). Capability to submit electronic syndromic surveillance data to public health agencies and actual submission except where prohibited and in accordance with applicable law and practice Successful ongoing submission of electronic syndromic surveillance data from CEHRT to a public health agency for the entire EHR reporting period. Automatically track medications from order to administration using assistive technologies in conjunction with an emar More than 10% of medication orders created by authorized providers during the EHR reporting period for which all doses are tracked are tracked using emar.
16 Stage 2 Menu Objectives for Hospitals and CAHs Must meet 3 of 6 Menu Objective Record advance directives for patients 65 years old or older Imaging Results Family History Generate and transmit permissible discharge prescriptions electronically (e- Rx) Record electronic notes in patient records Provide structured electronic lab results to ambulatory providers Measure More than 50% of all unique patients 65 years old or older admitted inpatient department during the EHR reporting period have an indication of an advance directive status recorded as structured data More than 10% of all scans and tests whose result is an image ordered by an authorized provider for patients admitted to its inpatient or emergency department during the EHR reporting period are incorporated into or accessible through CEHRT. More than 20% of all unique patients admitted to the inpatient or emergency department during the EHR reporting period have a structured data entry for one or more first-degree relatives or an indication that family health history has been reviewed. More than 10% of hospital discharge medication orders for permissible prescriptions (for new or changed prescriptions) are compared to at least one drug formulary and transmitted electronically using CEHRT. Enter at least one electronic progress note created, edited and signed by an EP for more than 30% of unique patients admitted to the inpatient or emergency department during the EHR reporting period. Send structured electronic clinical lab results to the ordering provider for more than 20% of electronic lab orders received.
17 Stage 2 Changes Beginning in 2014 EHRs Meeting ONC 2014 Standards all EHR Incentive Programs participants will have to adopt CEHRT that meets ONC s Standards & Certification Criteria 2014 Final Rule Reporting Period Reduced to Three Months to allow providers time to adopt 2014 CEHRT and prepare for Stage 2, all participants will have a threemonth reporting period in 2014 Batch Reporting groups will be allowed to submit attestation information for all of their individual EPs in one file for upload to the Attestation System, rather than having each EP individually enter data.
18 Medicaid Changes Stage 2 changes the definition of what constitutes a Medicaid encounter, allowing patients covered by the Children's Health Insurance Program (CHIP) to be eligible for inclusion in most states. In Stage 1: Service rendered on any one day where Medicaid paid for all or part of the service or Medicaid paid the co-pays, cost-sharing, or premiums Medicaid patient volume for providers calculated across 90-day period in last calendar year (for EPs) or Federal fiscal year (for hospitals)
19 Medicaid Changes In Stage 2: Service rendered on any one day to a Medicaidenrolled individual, regardless of payment liability Includes zero-pay claims and encounters with patients in CHIP programs in States that have Medicaid expansion programs or in States with a combined Medicaid and CHIP program. Services can be included provider s Medicaid patient volume calculation as long as the services were provided to a beneficiary who is enrolled in Medicaid States have the option to allow providers to calculate Medicaid patient volume across 90-day period in last 12 months preceding provider s attestation
20 States with stand-alone CHIP programs Alabama Arizona Colorado Connecticut Georgia Kansas Mississippi New York Nevada Oregon Pennsylvania Utah Vermont Washington West Virginia Wyoming Texas
21 Definition of Hospital Based Providers EPs can demonstrate that they fund the acquisition, implementation, and maintenance of CEHRT, including supporting hardware and interfaces needed for meaningful use without reimbursement from an eligible hospital or CAH in lieu of using the hospital s CEHRT can be determined non-hospital-based and potentially receive an incentive payment
22 Patient Engagement Requirements for Patient Action: More than 5% of patients must send secure messages to their EP More than 5% of patients must access their health information online CMS is introducing exclusions based on broadband availability in the provider s county.
23 Electronic Information Exchange Providers must: Send a summary of care record for more than 50% of transitions of care and referrals Electronically transmit a summary of care for more than 10% of transitions of care and referrals Additionally, at least one summary of care document must be sent electronically to a recipient with different EHR vendor or to CMS test EHR.
24 Clinical Quality Measures CQM reporting will remain the same through EP CQMs 15 Eligible Hospital and CAH CQMs In 2012 and continued in 2013, there are two reporting methods available for reporting the Stage 1 measures: Attestation ereporting pilots In 2014, EPs must report on 9 of the 64 approved CQMs 9 specific to pediatrics Medicaid providers submit CQMs according to their statebased submission requirements.
25 Clinical Quality Measures All providers must select CQMs from at least 3 of the 6 HHS National Quality Strategy domains: Patient and Family Engagement Patient Safety Care Coordination Population and Public Health Efficient Use of Healthcare Resources Clinical Processes/Effectiveness
26 Pediatric Specific CQMs Title Measure Appropriate Testing for Children with Pharyngitis Percentage of children 2-18 years of age, who were diagnosed with pharyngitis, ordered an antibiotic and received a group A streptococcus (strep) test for the episode. Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents Chlamydia Screening for Women Percentage of patients 3-17 years of age who had an outpatient visit with a Primary Care Physician (PCP) or Obstetrician/Gynecologist (OB/GYN) and who had evidence of the following during the measurement period. Three rates are reported. Percentage of patients with height, weight, and body mass index (BMI) percentile documentation. Percentage of patients with counseling for nutrition. Percentage of patients with counseling for physical activity. Percentage of women years of age who were identified as sexually active and who had at least one test for Chlamydia during the measurement period. Use of Appropriate Medications for Asthma Percentage of patients 5-64 years of age who were identified as having persistent asthma and were appropriately prescribed medication during the measurement period.
27 Pediatric Specific CQMs (continued) Title Childhood Immunization Status Measure Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV), one measles, mumps and rubella (MMR); three H influenza type B (HiB); three hepatitis B (Hep B); one chicken pox (VZV); four pneumococcal conjugate (PCV); one hepatitis A (Hep A); two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday. Appropriate Treatment for Children with Upper Respiratory Infection (URI) Percentage of children 3 months-18 years of age who were diagnosed with URI and were not dispensed an antibiotic prescription on or three days after the episode. ADHD: Follow-Up Care for Children Prescribed Attention Deficit/Hyperactivity Disorder (ADHD) Medication Percentage of children 6-12 years of age and newly dispensed a medication for attention-deficit/hyperactivity disorder (ADHD) who had appropriate follow-up care. Two rates are reported. Percentage of children who had one follow-up visit with a practitioner with prescribing authority during the 30-Day Initiation Phase. Percentage of children who remained on ADHD medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two additional follow-up visits with a practitioner within 270 days (9 months) after the Initiation Phase ended.
28 Pediatric Specific CQMs (continued) Title Measure Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan Children who have dental decay or cavities Percentage of patients aged 12 years and older screened for clinical depression on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow-up plan is documented on the date of the positive screen. Percentage of children ages 0-20, who have had tooth decay or cavities during the measurement period.
29 MU Resources ONC Meaningful Use Stage 2 Homepage (Includes links to the text of the final rules, HHS and CMS press releases, and FAQs at the bottom of the page.) CMS Stage 2 Webpage ONC Fact Sheet: 2014 Edition Standards & Certification Criteria (S&CC) Final Rule CMS Stage 2 Overview Tipsheet Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals (EPs) CMS Stage 2 Fact Sheets Understanding the HIPAA Privacy Rule AAP Child Health Informatics Center, Meaningful Use Resources
Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs Last Updated: August, 2012
CORE OBJECTIVES (16 total) Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs Last Updated: August, 2012 Stage 1 Objective Use CPOE for medication orders directly entered by any licensed
Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals Last Updated: August, 2012
Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals Last Updated: August, 2012 CORE OBJECTIVES (17 total) Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Use CPOE for medication
Stage 1 vs. Stage 2 Comparison for Eligible Professionals
Stage 1 vs. Comparison for Eligible Professionals CORE OBJECTIVES (17 Total) Stage 1 Objective Stage 1 Measure Objective Measure Use CPOE for Medication orders directly entered by any licensed healthcare
TABLE 4: STAGE 2 MEANINGFUL USE OBJECTIVES AND ASSOCIATED MEASURES SORTED BY CORE AND MENU SET
CMS-0044-P 156 TABLE 4: STAGE 2 MEANINGFUL USE OBJECTIVES AND ASSOCIATED MEASURES SORTED BY CORE AND MENU SET Improving quality, safety, efficiency, and reducing health disparities Use computerized provider
Reporting Period: For Stage 2, the reporting period must be the entire Federal Fiscal Year.
Eligible Hospital and Critical Access Hospital (CAH) Attestation Worksheet for Stage 2 of the Medicare Electronic Health Record (EHR) Incentive Program The Eligible Hospital and CAH Attestation Worksheet
STAGE 2 MEANINGFUL USE CORE AND MENU MEASURES FOR ELIGIBLE PROFESSIONALS
STAGE 2 MEANINGFUL USE CORE AND MENU MEASURES FOR ELIGIBLE PROFESSIONALS CORE MEASURES must meet all CPOE for Medication, Laboratory and Radiology Orders Objective: Use computerized provider order entry
Stage 2 Final Rule Overview: Updates to Stage 1 and New Stage 2 Requirements
Stage 2 Final Rule Overview: Updates to Stage 1 and New Stage 2 Requirements The Centers for Medicare and Medicaid Services (CMS) issued the Stage 2 Final Rule on September 4, 2012. The Stage 2 Final Rule
TABLE B5: STAGE 2 OBJECTIVES AND MEASURES
294 TABLE B5: STAGE 2 OBJECTIVES AND MEASURES CORE SET Improving quality, safety, efficiency, and reducing health disparities Use computerized provider order entry (CPOE) for medication, laboratory and
Regulations Overview
Meaningful Use - Stage 2 Regulations Overview Brought to you by Presented by: Travis Broome, MPH, MBA September 18, 2012 Objectives Specific regulatory changes and requirements based on the CMS Stage 2
Electronic Health Record (EHR) Incentive Program. Stage 2 Final Rule Update Part 2
Office of Medical Assistance Programs Electronic Health Record (EHR) Incentive Program Stage 2 Final Rule Update Part 2 November 7, 2012 Medical Assistance HIT Initiative 1 Office of Medical Assistance
Presented by. Terri Gonzalez Director of Practice Improvement North Carolina Medical Society
Presented by Terri Gonzalez Director of Practice Improvement North Carolina Medical Society Meaningful Use is using certified EHR technology to: Improve quality, safety, efficiency, and reduce errors Engage
LOOKING FORWARD TO STAGE 2 MEANINGFUL USE. 2012 Louisiana HIPAA & EHR Conference Presenter: Kathleen Keeley
LOOKING FORWARD TO STAGE 2 MEANINGFUL USE 2012 Louisiana HIPAA & EHR Conference Presenter: Kathleen Keeley Topics of Discussion Stage 2 Eligibility Stage 2 Meaningful Use Clinical Quality Measures Payment
Meaningful Use. Medicare and Medicaid EHR Incentive Programs
Meaningful Use Medicare and Medicaid Table of Contents What is Meaningful Use?... 1 Table 1: Patient Benefits... 2 What is an EP?... 4 How are Registration and Attestation Being Handled?... 5 What are
MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY
MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY STAGE 2 REQUIREMENTS EPs must meet or qualify for an exclusion to 17 core objectives EPs must meet 3 of the 6 menu measures.
STAGE 2 of the EHR Incentive Programs
EHR Incentive Programs A program administered by the Centers for Medicare & Medicaid Services (CMS) Eligible Professional s Guide to STAGE 2 of the EHR Incentive Programs September 2013 TABLE OF CONTENTS...
EHR Incentive Program Stage 2 Objectives Summary CORE OBJECTIVES (You must meet all objectives unless exclusion applies.)
EHR Incentive Program Stage 2 Objectives Summary CORE OBJECTIVES (You must meet all objectives unless exclusion applies.) TARGETING CANCER CARE Objective Objective Description Measure/Attestation Requirement
Meaningful Use Criteria for Eligible Hospitals and Eligible Professionals (EPs)
Meaningful Use Criteria for Eligible and Eligible Professionals (EPs) Under the Electronic Health Record (EHR) meaningful use final rules established by the Centers for Medicare and Medicaid Services (CMS),
Meaningful Use - The Basics
Meaningful Use - The Basics Presented by PaperFree Florida 1 Topics Meaningful Use Stage 1 Meaningful Use Barriers: Observations from the field Help and Questions 2 What is Meaningful Use Meaningful Use
Stage 2 Overview Tipsheet Last Updated: August, 2012
Stage 2 Overview Tipsheet Last Updated: August, 2012 Overview CMS recently published a final rule that specifies the Stage 2 criteria that eligible professionals (EPs), eligible hospitals, and critical
MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY
MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY On August 24, the Centers for Medicare & Medicaid Services (CMS) posted the much anticipated final rule for Stage
STAGES 1 AND 2 REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1
STAGES 1 AND 2 REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1 Requirement CPOE Use CPOE for medication orders directly entered by any licensed health care professional who can enter orders into the
Contact Information: West Texas Health Information Technology Regional Extension Center 3601 4 th Street MS 6232 Lubbock, Texas 79424 806-743-1338
Contact Information: West Texas Health Information Technology Regional Extension Center 3601 4 th Street MS 6232 Lubbock, Texas 79424 806-743-1338 http://www.wtxhitrec.org/ Grant award - $6.6m Total number
Meaningful Use Objectives
Meaningful Use Objectives The purpose of the electronic health records (EHR) incentive program is not so much the adoption of health information technology (HIT), but rather how HIT can further the goals
Meaningful Use Stage 2
Meaningful Use Stage 2 Presented by: Sarah Leake, HTS Consultant HTS, a division of Mountain Pacific Quality Health Foundation 1 HTS Who We Are Stage 2 MU Overview Learning Objectives 2014 CEHRT Certification
Meaningful Use: Stage 1 and 2 Hospitals (EH) and Providers (EP) Lindsey Mongold, MHA HIT Practice Advisor Oklahoma Foundation for Medical Quality
Meaningful Use: Stage 1 and 2 Hospitals (EH) and Providers (EP) Lindsey Mongold, MHA HIT Practice Advisor Oklahoma Foundation for Medical Quality Meaningful Use Stage 1 Focuses on Functional & Interoperability
Stage 2 of Meaningful Use: Ten Points of Interest
November 8, 2012 Practice Group: Health Care Stage 2 of Meaningful Use: Ten Points of Interest By Patricia C. Shea On September 4, 2012, the Department of Health and Human Services, Centers for Medicare
Medicare & Medicaid EHR Incentive Programs. Stage 1 and Stage 2 of Meaningful Use National Provider Call July 24, 2013
Medicare & Medicaid EHR Incentive Programs Stage 1 and Stage 2 of Meaningful Use National Provider Call July 24, 2013 Medicare Learning Network This MLN Connects National Provider Call (MLN Connects Call)
Medicare & Medicaid EHR Incentive Programs- Past, Present, & Future. Travis Broome, Centers for Medicare & Medicaid Services 12/18/2012
Medicare & Medicaid EHR Incentive Programs- Past, Present, & Future Travis Broome, Centers for Medicare & Medicaid Services 12/18/2012 Medicare-only Eligible Professionals Medicaid-only Eligible Professionals
CMS EHR Incentive Programs:
CMS EHR Incentive Programs: An Overview Meaningful Use Stages Vidya Sellappan Centers for Medicare & Medicaid Services Office of E-Health Standards and Services HIT Initiatives Group August 13, 2014 Table
EMR Name/ Model. meridianemr 4.2 CCHIT 2011 certified
EMR Name/ Model EMR Vendor meridianemr 4.2 CCHIT 2011 certified meridianemr, Inc Core Set of Measures Objective Stage 1 Objectives Stage 1 Measures EMR Module/ Feature 1 Use CPOE for medication orders
EMR Name/ Model. Cerner PowerChart Ambulatory (PowerWorks ASP)
EMR Name/ Model EMR Vendor Cerner PowerChart Ambulatory (PowerWorks ASP) Cerner Corporation Core Set of Measures 1 Use CPOE for medication orders directly entered by any licensed healthcare professional
Meaningful Use Stage 2 Implementation Guide
Meaningful Use Stage 2 Implementation Guide Copyright 2014 Kareo, Inc. All rights reserved. Updated October 2014 Table of Contents Get Ready... 1 Task List: Meaningful Use Stage 2... 2 Basic Training...
MDeverywhere, Inc. Presents 2014 CMS EHR Incentive Program Requirements: What Providers Need To Know
MDeverywhere, Inc. Presents 2014 CMS EHR Incentive Program Requirements: What Providers Need To Know Presented by: Kristen Heffernan Director Product Management & Marketing, Henry Schein MicroMD Agenda
Meaningful Use Updates Stage 2 and 3. Julia Moore, Business Analyst SMC Partners, LLC July 8, 2015
Meaningful Use Updates Stage 2 and 3 Julia Moore, Business Analyst SMC Partners, LLC July 8, 2015 Stage 2 Requirements 2015 EPs beyond 1st year of MU must report on a full year of data EPs in 1 st year
Achieving Meaningful Use with Centricity EMR
GE Healthcare Achieving Meaningful Use with Centricity EMR Are you Ready to Report? GE Healthcare EMR Consulting CHUG Fall Conference October 2010 Achieving Meaningful Use with Centricity EMR The EMR Consulting
Meaningful Use Stage 1:
Whitepaper Meaningful Use Stage 1: EHR Incentive Program Information -------------------------------------------------------------- Daw Systems, Inc. UPDATED: November 2012 This document is designed to
Stage 2 of Meaningful Use Summary of Proposed Rule
Stage 2 of Meaningful Use Summary of Proposed Rule Background In order to receive incentives for the adoption of electronic health records (EHRs) under either the Medicare or Medicaid (Medi-Cal) incentive
Medicaid EHR Incentive Program. Focus on Stage 2. Kim Davis-Allen, Outreach Coordinator [email protected]
Medicaid EHR Incentive Program Focus on Stage 2 Kim Davis-Allen, Outreach Coordinator [email protected] Understanding Participation Program Year Program Year January 1 st - December 31st. Year
hospital s or CAH s inpatient or professional guidelines
EMR Name/ Model EMR Vendor XLEMR/XLEMR-2011-MU XLEMR Objective 1 Core Set of Measures Use CPOE for medication orders Use CPOE for medication orders More than 30% of unique patients directly entered by
Agenda. What is Meaningful Use? Stage 2 - Meaningful Use Core Set. Stage 2 - Menu Set. Clinical Quality Measures (CQM) Clinical Considerations
AQAF Health Information Technology Forum Meaningful Use Stage 2 Clinical Considerations Marla Clinkscales & Mike Bice Alabama Regional Extension Center (ALREC) August 13, 2013 0 Agenda What is Meaningful
Incentives to Accelerate EHR Adoption
Incentives to Accelerate EHR Adoption The passage of the American Recovery and Reinvestment Act (ARRA) of 2009 provides incentives for eligible professionals (EPs) to adopt and use electronic health records
Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition
Ophthalmology Meaningful Use Attestation Guide Stage 1 2013 Edition Ophthalmologists can register for the Medicare electronic health record (EHR) incentive program on the CMS website: https://ehrincentives.cms.gov
Stage 1 Meaningful Use - Attestation Worksheet: Core Measures
Stage 1 Meaningful Use - Attestation Worksheet: Core Measures Core Measures Objective # Objective Title / Explanation Goal Attestation Response - Values below reflect reponses of most radiologists Explanation
E Z BIS ELECTRONIC HEALTH RECORDS
E Z BIS ELECTRONIC HEALTH RECORDS CERTIFICATION AND THE HITECH INCENTIVE PROGRAM The Incentives On July 13, 2010, the U.S. Department of Health and Human Services finalized the Electronic Health Record
Meaningful Use Stage 2. Presenter: Linda Wise, EMR Training Specialist
Meaningful Use Stage 2 Presenter: Linda Wise, EMR Training Specialist 1 AGENDA 2 Agenda Meaningful Use in Review Moving Into Stage 2 Meaningful Use Learning the Requirements Understanding the Measures
DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015
DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015 The chart below lists the measures (and specialty exclusions) that eligible providers must
Stage 2 Meaningful Use What the Future Holds. Lindsey Wiley, MHA HIT Manager Oklahoma Foundation for Medical Quality
Stage 2 Meaningful Use What the Future Holds Lindsey Wiley, MHA HIT Manager Oklahoma Foundation for Medical Quality An Important Reminder For audio, you must use your phone: Step 1: Call (866) 906-0123.
DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014
DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014 The chart below lists the measures (and specialty exclusions) that eligible providers must
Webinar #1 Meaningful Use: Stage 1 & 2 Comparison CPS 12 & UDS 2013
New York State-Health Centered Controlled Network (NYS HCCN) Webinar #1 Meaningful Use: Stage 1 & 2 Comparison CPS 12 & UDS 2013 January 31, 2014 Ekem Merchant-Bleiberg, Director of Implementation Services
Meaningful Use Stage 2 MU Audits
Meaningful Use Stage 2 MU Audits Presented by: Deb Anderson, CPHIMS HTS Consultant HTS, a division of Mountain Pacific Quality Health Foundation 1 CEHRT Certified Electronic Health Record Technology (EHR)
Meaningful Use 2015 and beyond. Presented by: Anna Mrvelj EMR Training Specialist
Meaningful Use 2015 and beyond Presented by: Anna Mrvelj EMR Training Specialist 1 Agenda A look at the CMS Website Finding your EMR version Certification Number Proposed Rule by the Centers for Medicare
Achieving Meaningful Use Training Manual
Achieving Meaningful Use Training Manual Terms EP Eligible Professional Medicare Eligible Professional o Doctor of Medicine or Osteopathy o Doctor of Dental Surgery or Dental Medicine o Doctor of Podiatric
Agenda. Overview of Stage 2 Final Rule Impact to Program
Electronic Health Record (EHR) Incentive Payment Program Review of Meaningful Use Stage 2 Regulation Changes and Other Impacts to the Medicaid EHR Incentive Program for 2014 that combines the effective
MEETING MEANINGFUL USE IN MICROMD -STAGE TWO- Presented by: Anna Mrvelj EMR Training Specialist
MEETING MEANINGFUL USE IN MICROMD -STAGE TWO- Presented by: Anna Mrvelj EMR Training Specialist 1 Proposed Rule On April 15, 2015 CMS Issued a new proposal rule for the Medicare and Medicaid EHR Incentive
An Overview of Meaningful Use: FAQs
An Overview of Meaningful Use: FAQs On Feb. 17, 2009, President Obama signed the American Recovery and Reinvestment Act of 2009 (ARRA) into law. This new law includes provisions (known as the HITECH Act)
Health Care February 28, 2012. CMS Issues Proposed Rule on Stage 2 Meaningful Use,
ROPES & GRAY ALERT Health Care February 28, 2012 CMS Issues Proposed Rule on Stage 2 Meaningful Use, ONC Issues Companion Proposed Rule on 2014 EHR Certification Criteria On February 23, 2012, the Centers
Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method
Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method Use Computerized Provider Order Entry (CPOE) for medication orders directly entered by
NY Medicaid EHR Incentive Program. Eligible Professionals Meaningful Use Stage 2 (MU2) Webinar www.emedny.org/meipass
Eligible Professionals Meaningful Use Stage 2 (MU2) Webinar www.emedny.org/meipass May 2015 2 Meaningful Use Stage 2 Overview of EHR Introduction to Meaningful Use Meaningful Use Stage 2 Objectives Clinical
AAP Meaningful Use: Certified EHR Technology Criteria
AAP Meaningful Use: Certified EHR Technology Criteria On July 13, 2010, the US Centers for Medicare and Medicaid Services (CMS) released a Final Rule establishing the criteria with which eligible pediatricians,
Appendix 2. PCMH 2014 and CMS Stage 2 Meaningful Use Requirements
Appendix 2 PCMH 2014 and CMS Stage 2 Meaningful Use Requirements Appendix 2 PCMH 2014 and CMS Stage 2 Meaningful Use Requirements 2-1 APPENDIX 2 PCMH 2014 AND CMS STAGE 2 MEANINGFUL USE REQUIREMENTS Medicare
Stage 1 Meaningful Use for Specialists. NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene
Stage 1 Meaningful Use for Specialists NYC REACH Primary Care Information Project NYC Department of Health & Mental Hygiene 1 Today s Agenda Meaningful Use Overview Meaningful Use Measures Resources Primary
Meaningful Use Cheat Sheet CORE MEASURES: ALL REQUIRED # Measure Exclusions How to Meet in WEBeDoctor
Meaningful Use Cheat Sheet CORE MEASURES: ALL REQUIRED # Measure Exclusions How to Meet in WEBeDoctor 1 CPOE (Computerized Physician Order Entry) More than 30 percent of all unique patients with at least
Alaska Medicaid Program
Alaska Medicaid Program ALASKA ELECTRONIC HEALTH RECORDS Incentive Program Updated April 2014 Provider Manual 1 Background... 4 2 How Do I use this manual?... 6 3 How do I get help?... 7 4 Eligible provider
Overview of MU Stage 2 Joel White, Health IT Now
Overview of MU Stage 2 Joel White, Health IT Now 1 Agenda 1. Introduction 2. Context 3. Adoption Rates of HIT 4. Overview of Stage 2 Rules 5. Overview of Issues 6. Trend in Standards: Recommendations v.
Understanding Meaningful Use Stage 2
Understanding Meaningful Use Stage 2 Miranda Ladue, Manager, Product Management Adam Plotts, Manager, Product Management Copyright 2011 Allscripts Healthcare Solutions, Inc. Agenda Review MU Timeline MU
Meaningful Use in 2015 and Beyond Changes for Stage 2
Meaningful Use in 2015 and Beyond Changes for Stage 2 Jennifer Boaz Transformation Support Specialist Proprietary 1 Definitions AIU = Adopt, Implement or Upgrade EP = Eligible Professional API = Application
VIII. Dentist Crosswalk
Page 27 VIII. Dentist Crosswalk Overview The final rule on meaningful use requires that an Eligible Professional (EP) report on both clinical quality measures and functional objectives and measures. While
Meaningful Use Qualification Plan
Meaningful Use Qualification Plan Overview Certified EHR technology used in a meaningful way is one piece of a broader Health Information Technology infrastructure intended to reform the health care system
Adopting an EHR & Meaningful Use
Adopting an EHR & Meaningful Use Learn how to qualify for the EHR Incentive Program The materials in this presentation, or prepared as part of this presentation, are provided for informational purposes
EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview
EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview CMS recently released a final rule that specifies criteria that eligible professionals (EPs), eligible hospitals, and critical access
A Guide to Understanding and Qualifying for Meaningful Use Incentives
A Guide to Understanding and Qualifying for Meaningful Use Incentives A White Paper by DrFirst Copyright 2000-2012 DrFirst All Rights Reserved. 1 Table of Contents Understanding and Qualifying for Meaningful
Meaningful Use of Certified EHR Technology with My Vision Express*
Insight Software, LLC 3050 Universal Blvd Ste 120 Weston FL 33331-3528 Tel. 877-882-7456 www.myvisionexpress.com Meaningful Use of Certified EHR Technology with My Vision Express* Eligible Professional
AETNA BETTER HEALTH OF MISSOURI
Aetna Better Health of Missouri 10 South Broadway, Suite 1200 St. Louis, MO 63102 800-566-6444 AETNA BETTER HEALTH OF MISSOURI HEDIS Quick Reference Billing Guide 2014 Diagnosis and/or procedure codes
Overview of the EHR Incentive Program
Overview of the EHR Incentive Program presented by Meaningful Use Stages 1 & 2 1 P Automated coding P Chief-complaint-driven P AnticiPlate Technology P Point-and-Click Functionality P erx through Surescripts
MEANINGFUL USE. Community Center Readiness Guide Additional Resource #13 Meaningful Use Implementation Tracking Tool (Template) CONTENTS:
Community Center Readiness Guide Additional Resource #13 Meaningful Use Implementation Tracking Tool (Template) MEANINGFUL USE HITECH s goal is not adoption alone but meaningful use of EHRs that is, their
The EP/eligible hospital has enabled this functionality. At least 80% of all unique patients. seen by the EP or admitted to the
EMR Name/Model EMR Vendor Allscripts Stage 1 objectives Eligible professionals Hospitals Use CPOE Use of CPOE for orders (any type) directly entered by authorizing provider (for example, MD, DO, RN, PA,
0 What is Meaningful Use and where are we? 0 What is the Physician Quality Reporting System and where stage are we on?
Outline 0 What is Meaningful Use and where are we? 0 What is the Physician Quality Reporting System and where stage are we on? 0 How can we leverage the EMR to demonstrate the quality of our care? Meaningful
